GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 80 filers reported holding GLYCOMIMETICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | -86.1% | 36,630 | -84.9% | 0.00% | – |
| Q2 2022 | $144,000 | -50.5% | 242,023 | -5.3% | 0.00% | – |
| Q1 2022 | $291,000 | -24.4% | 255,684 | -4.5% | 0.00% | – |
| Q4 2021 | $385,000 | -44.5% | 267,871 | -15.4% | 0.00% | -100.0% |
| Q3 2021 | $694,000 | +12.7% | 316,786 | +19.3% | 0.00% | 0.0% |
| Q2 2021 | $616,000 | -60.3% | 265,471 | -48.5% | 0.00% | 0.0% |
| Q1 2021 | $1,553,000 | -28.5% | 515,898 | -10.7% | 0.00% | -50.0% |
| Q4 2020 | $2,172,000 | +74.3% | 577,625 | +42.4% | 0.00% | +100.0% |
| Q3 2020 | $1,246,000 | -17.0% | 405,717 | +1.6% | 0.00% | -50.0% |
| Q2 2020 | $1,502,000 | +241.4% | 399,303 | +106.6% | 0.00% | +100.0% |
| Q1 2020 | $440,000 | +6.3% | 193,281 | +147.3% | 0.00% | – |
| Q4 2019 | $414,000 | +95.3% | 78,171 | +58.9% | 0.00% | – |
| Q3 2019 | $212,000 | +19.8% | 49,202 | +352.3% | 0.00% | – |
| Q1 2018 | $177,000 | -93.1% | 10,878 | -92.9% | 0.00% | -100.0% |
| Q4 2017 | $2,560,000 | – | 152,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,361,801 | $31,729,000 | 3.33% |
| NEA Management Company, LLC | 9,089,041 | $39,174,000 | 3.24% |
| Camber Capital Management LP | 3,500,000 | $15,085,000 | 0.79% |
| Redmile Group, LLC | 1,997,647 | $8,610,000 | 0.29% |
| Alambic Investment Management, L.P. | 41,698 | $180,000 | 0.14% |
| CAXTON CORP | 26,575 | $115,000 | 0.13% |
| PRENTISS SMITH & CO INC | 17,000 | $73,000 | 0.05% |
| Virtus ETF Advisers LLC | 22,580 | $97,000 | 0.02% |
| AXA S.A. | 1,825,738 | $7,868,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 30,000 | $129,000 | 0.01% |